US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Partners LP

51.28

-0.4100-0.79%

Post-market: 51.280.00000.00%16:01 EDT

Volume:40.79K

Turnover:2.09M

Market Cap:1.73B

PE:21.28

High:52.68

Open:52.02

Low:49.86

Close:51.69

Loading ...

Overview Company News Filings

Aon (NYSE:AON) Unveils Data-Driven GLP-1 Initiative For Workforce Health Improvement

Simply Wall St.

Aon Unveils First Workforce-Focused Analysis on GLP-1s: Medications and Holistic Support Can Transform Workforce Health and Bend the Cost Curve

GLP J-REIT Announces Strategic Asset Sale to Boost Dividends

GLP J-REIT Revises Forecasts Upward Following Asset Sale

Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership

Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss

Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

PepsiCo CEO was grilled about GLP-1s by a 13-year-old on his Q1 conference call

Global Partners Declares First-Quarter 2025 Cash Distribution of $0.7450 on Common Units

Press Release: Global Partners LP to Host First-Quarter 2025 Financial Results Conference Call on May 8, 2025

Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment

Lexaria Bioscience: A Key Player in the Future of Oral GLP-1 Drugs

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology

ACCESS Newswire

MetaVia Reports Additional Positive Top-Line Results From the MAD Part 2 of Its Phase 1 Study of DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist to Treat Obesity, Further Demonstrating Its Best-In-Class Potential

Eli Lilly & Co: Strong Growth Potential in GLP-1 Obesity Market with Positive Financial Outlook

Buy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market

Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Leerink bullish on Eli Lilly after ‘picture-perfect’ Phase 3 oral GLP-1 results

DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GLP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners LP","latestPrice":51.28,"timestamp":1746043200000,"preClose":51.69,"halted":0,"volume":40790,"hourTrading":{"tag":"盘后","latestPrice":51.28,"preClose":51.28,"latestTime":"16:01 EDT","volume":9797,"amount":502390.16000000003,"timestamp":1746043286913},"delay":0,"floatShares":25096277,"shares":33668256,"eps":2.41,"marketStatus":"Post-Mkt","change":-0.41,"latestTime":"04-30 16:02:27 EDT","open":52.02,"high":52.68,"low":49.86,"amount":2090674.84847,"amplitude":0.054556,"askPrice":52.27,"askSize":32,"bidPrice":50.29,"bidSize":17,"shortable":3,"etf":0,"ttmEps":2.41,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":51.69,"postHourTrading":{"tag":"盘后","latestPrice":51.28,"preClose":51.28,"latestTime":"16:01 EDT","volume":9797,"amount":502390.16000000003,"timestamp":1746043286913},"volumeRatio":1.584595,"impliedVol":0.3021,"impliedVolPercentile":0.212},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":25096277,"roa":"4.19%","roe":"14.20%","lyrEps":2.44604,"volumeRatio":1.584595,"shares":33668256,"dividePrice":2.98,"high":52.68,"amplitude":0.054556,"preClose":51.69,"low":49.86,"week52Low":37.0034,"pbRate":"2.69","psRate":"0.10","week52High":60,"institutionHeld":0.407,"latestPrice":51.28,"committee":-0.306122,"eps":2.41,"divideRate":0.058112,"volume":40790,"delay":0,"ttmEps":2.41,"open":52.02,"prevYearClose":46.55,"prevWeekClose":51.87,"prevMonthClose":53.38,"prevQuarterClose":53.38,"fiveDayClose":51.74,"twentyDayClose":54.83,"sixtyDayClose":56.75,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532706134","title":"Aon (NYSE:AON) Unveils Data-Driven GLP-1 Initiative For Workforce Health Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2532706134","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532706134?lang=en_us&edition=fundamental","pubTime":"2025-05-01 01:29","pubTimestamp":1746034171,"startTime":"0","endTime":"0","summary":"Over the last quarter, Aon introduced significant health initiatives, including launching its GLP-1 weight management program targeting obesity-related costs, which could suggest long-term strategic benefits. However, despite potential cost-saving implications and health benefits from these new offerings, Aon's share price dipped by 5% during the quarter, contrary to the market's 5% rise. The decline followed a Q1 earnings report revealing a drop in net income compared to last year. Additionally, broader market conditions, like weaker GDP data and declining tech stocks, likely weighed negatively on Aon's stock performance.We've spotted 1 weakness for Aon you should be aware of.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aon-nyse-aon-unveils-data-172931488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0251142724.SGD","BK4144","LU1691799644.USD","SG9999014914.USD","LU0157215616.USD","BK4559","LU1983260115.SGD","SG9999014880.SGD","LU0251131958.USD","LU0048573561.USD","BK4590","LU0742534661.SGD","BK4173","SG9999018857.SGD","SG9999017495.SGD","BK4585","NYSE","LU1366333091.USD","LU2236285917.USD","BK4588","SG9999018865.SGD","LU0077335932.USD","SG9999014898.SGD","LU2265009873.SGD","IE00BFXG1179.USD","GLP","BK4532","SG9999014906.USD","SGXZ31699556.SGD","LU1804176565.USD","AON"],"gpt_icon":0},{"id":"2531634084","title":"Aon Unveils First Workforce-Focused Analysis on GLP-1s: Medications and Holistic Support Can Transform Workforce Health and Bend the Cost Curve","url":"https://stock-news.laohu8.com/highlight/detail?id=2531634084","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531634084?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:00","pubTimestamp":1746007200,"startTime":"0","endTime":"0","summary":"Firm also sets new standard in employee health by combining GLP-1 medications and holistic support to drive adherence and sustainable outcomes for Aon's U.S. colleagues in collaboration with eMed. CHICAGO, April 30, 2025 /PRNewswire/ --Aon plc , a leading global professional services firm, today released findings from a multi-year study of U.S. commercial health claims data for more than 50 million commercially insured lives. The analysis highlights a significant opportunity to reduce healthcare costs for employers and enhance overall workforce health through a comprehensive obesity management program that includes GLP-1 medications.A Bend in the Cost Curve:After the widely reported initial jump in costs related to initiation of GLP-1 medications, cost growth rates diverge from the GLP-1 treatment group, trending at half the rate of a precisely matched control group in the last 12 months of the analysis period. Outside the cost of the treatment, Aon observed a seven-percentage point im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aon-unveils-first-workforce-focused-100000155.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aon-unveils-first-workforce-focused-100000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0157215616.USD","SG9999014880.SGD","BK4559","BK4173","BK4144","LU0251131958.USD","LU1983260115.SGD","LU2265009873.SGD","LU0077335932.USD","BK4585","IE00BFXG1179.USD","LU2236285917.USD","SG9999014914.USD","LU1366333091.USD","BK4588","AON","LU0251142724.SGD","SG9999017495.SGD","SG9999014898.SGD","GLP","SGXZ31699556.SGD","LU1804176565.USD","LU0048573561.USD","SG9999018857.SGD","BK4590","SG9999014906.USD","BK4532","SG9999018865.SGD","LU1691799644.USD","LU0742534661.SGD"],"gpt_icon":0},{"id":"2531702557","title":"GLP J-REIT Announces Strategic Asset Sale to Boost Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2531702557","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531702557?lang=en_us&edition=fundamental","pubTime":"2025-04-30 16:37","pubTimestamp":1746002223,"startTime":"0","endTime":"0","summary":"GLP J-REIT ( ($JP:3281) ) just unveiled an announcement. GLP J-REIT has announced the sale of three logistics properties, totaling 23.5 billion yen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-announces-strategic-asset-sale-to-boost-dividends?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-announces-strategic-asset-sale-to-boost-dividends?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","BK4144","REIT","GLP"],"gpt_icon":0},{"id":"2531581702","title":"GLP J-REIT Revises Forecasts Upward Following Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2531581702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531581702?lang=en_us&edition=fundamental","pubTime":"2025-04-30 16:36","pubTimestamp":1746002210,"startTime":"0","endTime":"0","summary":"GLP J-REIT ( ($JP:3281) ) has issued an announcement. GLP J-REIT has revised its forecast for the fiscal period ending August 31, 2025, due to a si...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-revises-forecasts-upward-following-asset-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-revises-forecasts-upward-following-asset-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","REIT","GLP","BK4144"],"gpt_icon":0},{"id":"2531635756","title":"Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2531635756","media":"Yahoo Finance","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531635756?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:18","pubTimestamp":1745936291,"startTime":"0","endTime":"0","summary":"Hims & Hers  stock popped more than 20% in trading early Tuesday after Novo Nordisk  announced a partnership with it and other telehealth platforms to offer patients access to the blockbuster weight loss drug Wegovy.Novo's stock was also up, about 3% in early trading.Patients will be able to access the popular GLP-1 through Novo's online pharmacy, NovoCare, directly from Hims and telehealth providers Ro and LifeMD.In recent months, competitor Eli Lilly  has similarly opened up its direct-to-consumer pharmacy to platforms, as well as partnered with Ro to offer vials of Lilly's blockbuster weight loss drug Zepbound. Novo's partnership focuses on the injectable pens — the more popular form of the drug.Hims said patients can access the drug along with support services through memberships for a bundled price of $599 per month. The deal comes just ahead of the company's first quarter earnings report, but will not be reflected in the report.Two packages of 5 dosing pens each of a fictitious S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hims--hers-stock-jumps-on-novo-nordisk-glp-1-partnership-141811461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1712237335.SGD","LU0097036916.USD","LU0466842654.USD","LU0122379950.USD","LU0795875169.SGD","LU1732799900.SGD","LU1917777945.USD","LU2112291526.USD","LU0225283273.USD","LU0471298694.HKD","LU1127390331.HKD","LU1023059063.AUD","LU0417517546.SGD","IE00B1BXHZ80.USD","BK4504","BK4144","LU1074936037.SGD","LU1551013342.USD","LU1868837136.USD","LU0689472784.USD","LU1035775433.USD","NVO","SG9999014914.USD","LU2264538146.SGD","LU2028103732.USD","LU2602419157.SGD","LU1551013425.SGD","LU1061106388.HKD","LU1868836757.USD","LLY","LU0314104364.USD","LU2211815571.USD","SG9999017495.SGD","LU2347655156.SGD","LU0106261372.USD","LU1623119135.USD","GLP","LU1232071149.USD","LU0094547139.USD","HIMS","LU0106831901.USD","LU0079474960.USD","LU0820561909.HKD","LU1064131342.USD","LU1868836591.USD","LU2111349929.HKD","LU1291159041.SGD","LU2237443978.SGD","LU1868836914.USD","SG9999018857.SGD"],"gpt_icon":1},{"id":"2531365867","title":"Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2531365867","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531365867?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:38","pubTimestamp":1745930301,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to take a look at where Eli Lilly and Company  stands against other stocks that Jim Cramer discussed.On Friday, Mad Money host Jim Cramer took a close look at what he called one of the most important stretches of the earnings season, which came alongside major economic developments.“We made it. Yep, we got through another stretch without the White House upending the whole market, which therefore led to the second-best week of the year.”READ ALSOJim Cramer Put These 16 Stocks Under a MicroscopeandJim Cramer Recently Talked About These 15 Stocks. “Here’s the bottom line: This is a really consequential week ahead. We’re about to get into the weeds with tariffs, and we have to sort out what’s real and what’s just mandated by the president. Most important, we need to see some trade deals, please. With them, the market can absorb some earnings disappointments, but without t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-eli-lilly-company-123821312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LLY","US2Y.BOND","US5Y.BOND","LU0096364046.USD","LU1061106388.HKD","LU1291159041.SGD","GB00BDT5M118.USD","LU0689472784.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","US12M.BOND","US3Y.BOND","LU2552382215.SGD","LU2491049909.HKD","BK4599","LU1868837136.USD","LU0238689110.USD","LU1280957306.USD","SG9999017495.SGD","SGXZ99366536.SGD","US30Y.BOND","LU1868837300.USD","LU1804176565.USD","SG9999014914.USD","LU2491050071.SGD","BK4144","LU1720051108.HKD","GLP","IE00BJT1NW94.SGD","SG9999013999.USD","LU1064131342.USD","LU0882574055.USD","LU1551013342.USD","SG9999018865.SGD","US10Y.BOND","LU2106854487.HKD","US6M.BOND","IE00BK4W5M84.HKD","LU1868836757.USD","IE0004445239.USD","SG9999018857.SGD","US7Y.BOND","SGXZ81514606.USD","BK4516","IE0009355771.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU1720051017.SGD","BK4588"],"gpt_icon":1},{"id":"2531942392","title":"Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531942392","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531942392?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:30","pubTimestamp":1745872200,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass., April 28, 2025  -- Fractyl Health, Inc.  , a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes , today announced that it will deliver an oral presentation of compelling preclinical data from its Rejuva single-administration Smart GLP-1 pancreatic gene therapy platform at the American Society of Gene and Cell Therapy  2025 Annual Meeting, taking place May 13-17, 2025, in New Orleans, Louisiana.Title: Endoscopic Ultrasound-Guided Delivery of Human Glucagon-like Peptide-1 Pancreatic Gene Therapy: Safety and Feasibility in a Porcine ModelSession: AAV Preclinical and Proof-of-Concept StudiesDate and Time: Saturday, May 17, 2025, 9:15 a.m. – 9:30 a.m. CTLocation: NOLA Theater A. Investor Contact Brian Luque, Head of Investor Relations and Corporate DevelopmentIR@fractyl.com, 951.206.1200","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fractyl-health-present-compelling-preclinical-203000689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GLP","BK4107","BK4082","CTA","GUTS","AFG","BK4144","BK4117","BK4590"],"gpt_icon":0},{"id":"2531726700","title":"PepsiCo CEO was grilled about GLP-1s by a 13-year-old on his Q1 conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2531726700","media":"Fortune","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531726700?lang=en_us&edition=fundamental","pubTime":"2025-04-29 00:14","pubTimestamp":1745856853,"startTime":"0","endTime":"0","summary":"The 13-year-old daughter of a Jefferies analyst asked about the effect of GLP-1 oral medications during PepsiCo’s most recent quarterly earnings call, as part of “Bring your Kid to Work Day.” CEO Ramon Laguarta took the question seriously, saying his company was marketing snacks in smaller portions to target consumers with smaller appetites.PepsiCo CEO Ramon Laguarta was no doubt expecting tough questions during the company’s Q1 earnings call; what he probably wasn’t expecting was to be interrogated about the effect of pharmaceuticals on the human digestive system by a 13-year-old.Amid inquiries on revenue, tariffs, and volumes that could have comprised any other earnings call that day, Jefferies analyst Kaumil Gajrawala surprised Laguarta by letting his daughter Milena Gajrawala ask a question.Wall Street has a venerable history of extracting investment wisdom from teenagers. In 2009, 15-year-old Matthew Robson, an intern at Morgan Stanley, was allowed to write a research note on how ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepsico-ceo-grilled-glp-1s-161413815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GLP","PEP"],"gpt_icon":0},{"id":"2530375831","title":"Global Partners Declares First-Quarter 2025 Cash Distribution of $0.7450 on Common Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2530375831","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530375831?lang=en_us&edition=fundamental","pubTime":"2025-04-25 20:30","pubTimestamp":1745584200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April 25, 2025----Global Partners LP   today announced that the Board of Directors of its general partner, Global GP LLC, has declared a cash distribution of $0.7450 per unit  on all of its outstanding common units from January 1, 2025 through March 31, 2025. The distribution will be paid on May 15, 2025 to unitholders of record as of the close of business on May 9, 2025.Global Partners, a master limited partnership, trades on the New York Stock Exchange under the ticker symbol \"GLP.\" For additional information, visit www.globalp.com.Certain statements and information in this press release may constitute \"forward-looking statements.\" The words \"believe,\" \"expect,\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/global-partners-declares-first-quarter-123000143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2529798433","title":"Press Release: Global Partners LP to Host First-Quarter 2025 Financial Results Conference Call on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529798433","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529798433?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:33","pubTimestamp":1745497980,"startTime":"0","endTime":"0","summary":"Global Partners LP   today announced that it will release its first-quarter 2025 financial results before the market opens on Thursday, May 8, 2025. At 10:00 a.m. ET, the Partnership will conduct a conference call for investors and analysts hosted by Eric Slifka, President and Chief Executive Officer, Gregory B. Hanson, Chief Financial Officer, and Mark Romaine, Chief Operating Officer.Global Partners, a master limited partnership, trades on the New York Stock Exchange under the ticker symbol \"GLP.\" For additional information, visit www.globalp.com.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","HST","GLP","BK4588","BK4144","BK4181","BK4585","BK4218"],"gpt_icon":0},{"id":"2529354269","title":"Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2529354269","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529354269?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences received preliminary meeting responses from the FDA regarding Northstrive’s nonclinical studies and clinical development plans for EL-22, administered in combination with GLP-1 receptor agonists.Northstrive believes the FDA responses encourage a path forward for filing an IND application to conduct a Phase 2 clinical trial in overweight or obese patients.EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.NEWPORT BEACH, Calif., April 24, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , announced that it has received preliminary responses and commentary from the U.S. Food and Drug Administration  regarding its scheduled Type B pre-Investigational New Drug  meeting. Northstrive initially requested this meeting with the FDA to discuss nonclinical studies and Northstrive Biosciences’ clinical development p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-announces-positive-fda-120000281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4558","BK4585","GLP","BK4144","BK4533","LU2404859667.USD","BK4548","BK4504","LU2552382215.SGD","LU0690374615.EUR","ELAB","LU2552382058.USD","LU2404859741.USD","LU0690374961.EUR","BK4590","LU2552382132.HKD","EL","BK4183"],"gpt_icon":0},{"id":"2529383633","title":"Lexaria Bioscience: A Key Player in the Future of Oral GLP-1 Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529383633?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:37","pubTimestamp":1745419071,"startTime":"0","endTime":"0","summary":"An announcement from Lexaria Bioscience ( ($LEXX) ) is now available. Lexaria Bioscience is poised to play a significant role in the development of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexaria-bioscience-a-key-player-in-the-future-of-oral-glp-1-drugs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexaria-bioscience-a-key-player-in-the-future-of-oral-glp-1-drugs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2529868706","title":"Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2529868706","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529868706?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:10","pubTimestamp":1745413800,"startTime":"0","endTime":"0","summary":"Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry. Lexaria's technology could enhance performance and lower side effects. By enhancing the performance of oral dosing choices as a replacement for disliked injections; and by reducing adverse events - often the #1 reason that patients stop using GLP-1 drugs - Lexaria's proprietary DehydraTECH technology could be of vital importance to any of these companies in their pursuit of the next oral GLP-1 drug.Eli Lilly plans to apply for approval to launch the drug for both weight loss and diabetes treatment in 2026 - and that rapid path to market, combined with the fact that it might be only the 2nd oral GLP-1 drug to potentially be approved by the Food and Drug Administration , is likely responsible for the dramatic market response to the news.Although clearly a positive step forward for the weight loss and diabetes treatment sectors, it should still be noted that 13% to 18% of patients receiving the drug ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recent-glp-1-industry-developments-131000677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999003800.SGD","BK4590","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4007","BK4550","LU0122379950.USD","LU0321505868.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","LEXXW","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","GLP","SG9999013999.USD","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","BK4534","BK4144","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0306806265.USD","LU1057294990.SGD","IE0002270589.USD","LU1894683348.USD","LEXX"],"gpt_icon":1},{"id":"2529304614","title":"MetaVia Reports Additional Positive Top-Line Results From the MAD Part 2 of Its Phase 1 Study of DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist to Treat Obesity, Further Demonstrating Its Best-In-Class Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2529304614","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529304614?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:31","pubTimestamp":1745325060,"startTime":"0","endTime":"0","summary":"A Dose-Dependent Response in Body Weight Reduction Was Observed Between 8 mg and 32 mg Doses. Change in BMI and Body Weight Adjusted for Height In the Treatment Groups, Showed a Significant Difference Compared to Placebo, Indicating Potentially Greater Efficacy with Increasing Dosage and Longer Duration of Use. No Drug-Induced Cardiovascular Effects Were Observed In Heart Rate or QTcF Measurements of Subjects Receiving up to 32 mg of DA-1726 at 4-Weeks. Additional Cohorts Being Added to Determine Maximum Tolerated Dose. In the 28-day, 36-subject MAD portion of the study, a clear dose-responsive trend in body weight  reduction was observed across the 8 mg to 32 mg range, indicating potentially greater efficacy at higher doses and longer duration of use. Additionally, body mass index , which shows body weight adjusted for height, showed a difference between the treatment group and the placebo  group, which was even more pronounced, further supporting the dose-dependent effect of the drug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/metavia-reports-additional-positive-top-123100490.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/metavia-reports-additional-positive-top-123100490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MTVA","GLP"],"gpt_icon":0},{"id":"2529768653","title":"Eli Lilly & Co: Strong Growth Potential in GLP-1 Obesity Market with Positive Financial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2529768653","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529768653?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:36","pubTimestamp":1745318171,"startTime":"0","endTime":"0","summary":"Analyst Tim Anderson from Bank of America Securities reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/eli-lilly-co-strong-growth-potential-in-glp-1-obesity-market-with-positive-financial-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/eli-lilly-co-strong-growth-potential-in-glp-1-obesity-market-with-positive-financial-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU1718418525.SGD","LU0466842654.USD","IE00BZ1G4Q59.USD","SG9999014898.SGD","BK4144","LU0058720904.USD","LU0203202063.USD","SG9999001176.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU0106261372.USD","LU0289739699.SGD","LU1983299246.USD","LU1201861249.SGD","LU2468319806.SGD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU0943347566.SGD","LU0053666078.USD","BK4504","LU0094547139.USD","IE00B7SZLL34.SGD","IE00BFTCPJ56.SGD","LU1232071149.USD","SG9999014880.SGD","LU0456855351.SGD","LU1201861165.SGD","LLY","LU1868836591.USD","LU0052756011.USD","LU0314106906.USD","LU2552382132.HKD","IE00BLSP4452.SGD","LU1267930227.SGD","LU0882574139.USD","LU2237443549.SGD","LU0306806265.USD","LU2264538146.SGD","LU0672654240.SGD","LU2471134523.USD","LU0354030511.USD","GLP","LU1093756325.SGD","LU2089984988.USD","SG9999017495.SGD","SGXZ57979304.SGD","LU1035775433.USD"],"gpt_icon":0},{"id":"2529373320","title":"Buy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529373320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529373320?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:16","pubTimestamp":1745316987,"startTime":"0","endTime":"0","summary":"Analyst Ananda Ghosh from H.C. Wainwright maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report) and keepin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-structure-therapeutics-alenigliprons-competitive-edge-in-the-oral-glp-1-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-structure-therapeutics-alenigliprons-competitive-edge-in-the-oral-glp-1-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","LENZ"],"gpt_icon":0},{"id":"2529807972","title":"Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807972","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529807972?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:51","pubTimestamp":1745243460,"startTime":"0","endTime":"0","summary":"COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2  and a GLP-1 receptor agonist , designed to deliver a multi-targeted immunomodulatory therapeutic in autoimmune and neurodegenerative diseases. COYA 303 produced a statistically significantly higher Treg suppressive effect on pro-inflammatory myeloid cells and enhanced Treg survival in in vitro human immune cells, compared to the individual components - LD IL-2 and GLP-1RA. Dr. Fred Grossman, Coya’s Chief Medical Officer commented, \"We believe the encouraging results of this study provide support for our multi-targeted combination approach as a potentially viable treatment option for serious and life-threatening conditions of high unmet need driven by chronic inflammation and Treg dysfunction, for which currently av","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coya-therapeutics-announces-publication-glp-135100483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COYA","GLP","LD"],"gpt_icon":0},{"id":"2529138887","title":"LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529138887","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529138887?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:37","pubTimestamp":1745239020,"startTime":"0","endTime":"0","summary":"Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the primary goal of significantly reducing A1C levels compared to placebo at 40 weeks, with an average A1C reduction of 1.3% to 1.6% from a baseline of 8%. LLY’s orforglipron is an investigational, once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake.The phase III ACHIEVE-1 study, the first of sevenlate-stage studies, is evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes  and inadequate glycemic control with diet and exercise alone. The enrolled patients in the 40-week study were randomized equally to receive either a 3 mg, 12 mg or 36 mg dose of orforglipron or placebo. Lilly is also developing a version of this oral drug for obesity.Year to date, shares of Lilly have gained 8.8% against the industry’s 3.3% decline.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lly-stock-oral-glp-1-123700472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2089984988.USD","LU0096364046.USD","LU1023059063.AUD","LU0256863811.USD","LU1366192091.USD","LU1720051108.HKD","LU1868836757.USD","LU0471298777.SGD","LU2361044949.HKD","LU1712237335.SGD","IE00B2B36J28.USD","LU2360106947.USD","LU0456855351.SGD","LU2324357040.USD","LU1093756168.USD","VKTX","LU1868837300.USD","NVO","LU1280957306.USD","IE00BZ1G4Q59.USD","BK4534","LU2237443465.HKD","LU2264538146.SGD","LU2237443622.USD","LU0417517546.SGD","LLY","LU0640476718.USD","LU0094547139.USD","LU1035775433.USD","LU1551013342.USD","LU2106854487.HKD","LU2471134952.CNY","LU0943347566.SGD","SG9999017495.SGD","LU2237443382.USD","IE00BK4W5L77.USD","GPCR","LU1061106388.HKD","LU0354030511.USD","LU0114720955.EUR","IE0004445239.USD","LU1548497426.USD","III","GLP","SG9999018865.SGD","BK4581","LU0238689110.USD","LU1093756325.SGD","BK4532","LU1720051017.SGD"],"gpt_icon":1},{"id":"2528748215","title":"Leerink bullish on Eli Lilly after ‘picture-perfect’ Phase 3 oral GLP-1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2528748215","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528748215?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:30","pubTimestamp":1744896640,"startTime":"0","endTime":"0","summary":"Leerink notes Eli Lilly’s (LLY) once-daily oral GLP-1 pill showed similar efficacy and safety relative to weekly injectable semaglutide, made by No...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-bullish-on-eli-lilly-after-picture-perfect-phase-3-oral-glp-1-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-bullish-on-eli-lilly-after-picture-perfect-phase-3-oral-glp-1-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0354030511.USD","LU0820561909.HKD","LU1623119135.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU2471134879.HKD","LU1988902786.USD","LU0058720904.USD","SG9999014880.SGD","LU2237438978.USD","LU2468319806.SGD","IE00BK4W5M84.HKD","LU0109391861.USD","LU0006306889.USD","BK4007","SGXZ31699556.SGD","GB00BDT5M118.USD","LU0094547139.USD","LU0471298694.HKD","LU0640476718.USD","LU0882574139.USD","LU2237443978.SGD","LU0122379950.USD","LU1069344957.HKD","BK4588","IE00B4R5TH58.HKD","LU1868837300.USD","LU2602419157.SGD","LU2112291526.USD","LU1720051017.SGD","GLP","LU1064131342.USD","LU1974910355.USD","LU2360106947.USD","LU1868837136.USD","LU0456855351.SGD","LU1035775433.USD","LU1868836757.USD","BK4144","SG9999018857.SGD","SG9999014906.USD","SG9999015945.SGD","LU1712237335.SGD","LU1280957306.USD","LU2265009873.SGD","LU2552382215.SGD","LLY","LU0417517546.SGD","SG9999015952.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2528714949","title":"DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714949","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714949?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"Strategic partnership expands Dario's employer footprint and has already started contributing to recurring revenues in Q1 of 2025. \"We are thrilled to partner with one of the fastest growing benefits administrators in the country to support their goals of delivering market-leading health benefits that help reduce costs associated with healthcare,\" said Steven Nelson, Chief Commercial Officer at Dario. \"This strategic partnership unlocks new distribution channels that align with payer-driven models such as Third Party Administrators  and benefits platforms, as well as expanding in the employer market. Due to the shorter sales cycle, we were able to begin onboarding employers quickly after the January launch, with the ability to add employers off-cycle as well, maximizing the availability of Dario's solutions to the employer population and creating an immediate impact on our Business-to-Business-to-Consumer  recurring revenues for 2025. This partnership highlights our solution to the gro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/dariohealth-collaborates-leading-national-benefit-123000821.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dariohealth-collaborates-leading-national-benefit-123000821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","BK4167","DRIO","GLP","NHLD","BK4144","BK4107","EIG","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"GLP","amount":0.745,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-05-15"},{"date":"2025-05-08","symbol":"GLP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"defaultRemindTime":1746691200000,"name":null,"time":"Pre-Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-28","symbol":"GLP","fiscalQuarterEnding":"2024/12","expectedEps":0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":0.52},{"date":"2025-02-10","symbol":"GLP","amount":0.74,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-10","defaultRemindTime":1739197800000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-14","payableDate":"2025-02-10","currency":"USD","dateTimestamp":1739163600000,"payDate":"2025-02-14"},{"date":"2024-11-08","symbol":"GLP","amount":0.73,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-08","defaultRemindTime":1731076200000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-14","payableDate":"2024-11-08","currency":"USD","dateTimestamp":1731042000000,"payDate":"2024-11-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-04","recordDate":"2015-05-06","paymentDate":"2015-05-15","value":0.68,"currency":"USD"},{"executeDate":"2015-08-03","recordDate":"2015-08-05","paymentDate":"2015-08-14","value":0.6925,"currency":"USD"},{"executeDate":"2015-11-02","recordDate":"2015-11-04","paymentDate":"2015-11-13","value":0.6975,"currency":"USD"},{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-04-29","current":18.932447,"percent":0.893409,"low":2.771386,"twenty":4.270877,"median":9.726256,"eighty":15.400519,"high":29.34912,"avg":10.467168,"sd":6.269865,"marketCap":1748392534},"quantilePoints":[{"date":"2020-05-01","current":11.300646,"twenty":6.299659,"median":7.88907,"eighty":11.255307,"marketCap":389736665},{"date":"2020-05-08","current":11.690231,"twenty":6.299659,"median":7.896854,"eighty":11.255307,"marketCap":361461939},{"date":"2020-05-15","current":10.863092,"twenty":6.299659,"median":7.912422,"eighty":11.245121,"marketCap":335886802},{"date":"2020-05-22","current":11.182919,"twenty":6.299659,"median":7.932539,"eighty":11.262234,"marketCap":345775855},{"date":"2020-05-29","current":11.24909,"twenty":6.299659,"median":7.943558,"eighty":11.269162,"marketCap":347821866},{"date":"2020-06-05","current":12.451199,"twenty":6.307959,"median":7.955234,"eighty":11.298028,"marketCap":384991066},{"date":"2020-06-12","current":11.557889,"twenty":6.309309,"median":7.998046,"eighty":11.32112,"marketCap":357369917},{"date":"2020-06-19","current":11.072634,"twenty":6.3117,"median":8.066523,"eighty":11.332667,"marketCap":342365837},{"date":"2020-06-26","current":10.708693,"twenty":6.3117,"median":8.171888,"eighty":11.326893,"marketCap":331112776},{"date":"2020-07-02","current":10.752807,"twenty":6.317715,"median":8.211094,"eighty":11.322275,"marketCap":332476784},{"date":"2020-07-10","current":10.43298,"twenty":6.321861,"median":8.267451,"eighty":11.32112,"marketCap":322587731},{"date":"2020-07-17","current":10.13521,"twenty":6.32825,"median":8.287054,"eighty":11.316433,"marketCap":313380681},{"date":"2020-07-24","current":10.543265,"twenty":6.333279,"median":8.291955,"eighty":11.303569,"marketCap":325997749},{"date":"2020-07-31","current":11.800516,"twenty":6.334178,"median":8.348313,"eighty":11.303569,"marketCap":364871958},{"date":"2020-08-07","current":4.73435,"twenty":6.333279,"median":8.360564,"eighty":11.32112,"marketCap":438154667},{"date":"2020-08-14","current":5.006778,"twenty":6.3117,"median":8.298445,"eighty":11.316433,"marketCap":463367300},{"date":"2020-08-21","current":4.712262,"twenty":6.299659,"median":8.287054,"eighty":11.303569,"marketCap":436110400},{"date":"2020-08-28","current":4.701217,"twenty":6.299607,"median":8.274802,"eighty":11.298552,"marketCap":435088266},{"date":"2020-09-04","current":4.542915,"twenty":6.2824,"median":8.213544,"eighty":11.285346,"marketCap":420437682},{"date":"2020-09-11","current":4.749076,"twenty":6.27606,"median":8.174338,"eighty":11.274368,"marketCap":439517512},{"date":"2020-09-18","current":4.815342,"twenty":6.275736,"median":8.086126,"eighty":11.269162,"marketCap":445650315},{"date":"2020-09-25","current":4.73435,"twenty":6.258044,"median":8.00583,"eighty":11.265698,"marketCap":438154667},{"date":"2020-10-02","current":4.933149,"twenty":6.250305,"median":7.971673,"eighty":11.259925,"marketCap":456553075},{"date":"2020-10-09","current":5.360198,"twenty":6.244429,"median":7.94745,"eighty":11.2525,"marketCap":496075580},{"date":"2020-10-16","current":5.26448,"twenty":6.239772,"median":7.932539,"eighty":11.247278,"marketCap":487217087},{"date":"2020-10-23","current":5.271843,"twenty":6.23717,"median":7.912422,"eighty":11.243223,"marketCap":487898510},{"date":"2020-10-30","current":5.338109,"twenty":6.227089,"median":7.896854,"eighty":11.239367,"marketCap":494031312},{"date":"2020-11-06","current":5.459545,"twenty":6.22179,"median":7.88907,"eighty":11.21862,"marketCap":522855188},{"date":"2020-11-13","current":5.670214,"twenty":6.203808,"median":7.87934,"eighty":11.19873,"marketCap":543030764},{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":14.905887,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1589131510},{"date":"2024-06-07","current":15.724962,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1676453895},{"date":"2024-06-14","current":15.619789,"twenty":4.452456,"median":8.72747,"eighty":13.254699,"marketCap":1665241293},{"date":"2024-06-21","current":14.485195,"twenty":4.448612,"median":8.720183,"eighty":13.254699,"marketCap":1544281101},{"date":"2024-06-28","current":14.60949,"twenty":4.437079,"median":8.698559,"eighty":13.248042,"marketCap":1557532358},{"date":"2024-07-05","current":14.552123,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1551416394},{"date":"2024-07-12","current":13.854157,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1477005489},{"date":"2024-07-15","current":13.586443,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1448464320},{"date":"2024-08-02","current":13.149816,"twenty":4.293661,"median":8.639313,"eighty":12.179123,"marketCap":1401915033},{"date":"2024-08-09","current":12.65362,"twenty":4.293661,"median":8.639313,"eighty":12.333841,"marketCap":1357404400},{"date":"2024-08-16","current":12.71449,"twenty":4.293661,"median":8.639313,"eighty":12.422884,"marketCap":1363934183},{"date":"2024-08-23","current":13.275377,"twenty":4.293661,"median":8.639313,"eighty":12.626454,"marketCap":1424102779},{"date":"2024-08-30","current":14.261656,"twenty":4.293661,"median":8.639313,"eighty":13.112996,"marketCap":1529904861},{"date":"2024-09-06","current":13.281679,"twenty":4.293661,"median":8.639313,"eighty":13.211726,"marketCap":1424778831},{"date":"2024-09-13","current":13.861472,"twenty":4.293661,"median":8.639313,"eighty":13.294349,"marketCap":1486975582},{"date":"2024-09-20","current":13.839415,"twenty":4.293661,"median":8.639313,"eighty":13.376841,"marketCap":1484609401},{"date":"2024-09-27","current":14.00327,"twenty":4.293661,"median":8.639313,"eighty":13.543138,"marketCap":1502186744},{"date":"2024-10-04","current":14.854053,"twenty":4.293661,"median":8.639313,"eighty":13.653503,"marketCap":1593453715},{"date":"2024-10-11","current":14.854053,"twenty":4.293661,"median":8.639313,"eighty":13.84826,"marketCap":1593453715},{"date":"2024-10-18","current":14.737464,"twenty":4.293661,"median":8.639313,"eighty":13.994199,"marketCap":1580946760},{"date":"2024-10-25","current":15.008455,"twenty":4.293661,"median":8.639313,"eighty":14.123548,"marketCap":1610016980},{"date":"2024-10-31","current":14.655537,"twenty":4.293661,"median":8.639313,"eighty":14.202306,"marketCap":1572158088},{"date":"2024-11-08","current":15.118742,"twenty":4.28479,"median":8.64118,"eighty":14.37096,"marketCap":1621847884},{"date":"2024-11-15","current":13.409306,"twenty":4.28479,"median":8.692753,"eighty":14.37096,"marketCap":1673883715},{"date":"2024-11-22","current":14.009118,"twenty":4.28479,"median":8.746428,"eighty":14.37096,"marketCap":1748758223},{"date":"2024-11-29","current":15.251971,"twenty":4.28479,"median":8.78252,"eighty":14.384136,"marketCap":1903903601},{"date":"2024-12-06","current":15.416785,"twenty":4.28479,"median":8.81344,"eighty":14.484602,"marketCap":1924477227},{"date":"2024-12-13","current":14.881817,"twenty":4.28479,"median":8.908125,"eighty":14.552123,"marketCap":1857697260},{"date":"2024-12-20","current":12.709526,"twenty":4.28479,"median":8.950817,"eighty":14.552123,"marketCap":1586530122},{"date":"2024-12-27","current":12.995923,"twenty":4.28479,"median":9.012663,"eighty":14.552123,"marketCap":1622281013},{"date":"2025-01-03","current":12.674402,"twenty":4.28479,"median":9.065008,"eighty":14.552123,"marketCap":1582145578},{"date":"2025-01-10","current":12.901358,"twenty":4.275919,"median":9.188137,"eighty":14.552123,"marketCap":1610476474},{"date":"2025-01-17","current":14.179335,"twenty":4.275919,"median":9.277741,"eighty":14.552123,"marketCap":1770006394},{"date":"2025-01-24","current":13.960485,"twenty":4.275919,"median":9.31881,"eighty":14.552123,"marketCap":1742687317},{"date":"2025-01-31","current":15.316816,"twenty":4.275919,"median":9.382279,"eighty":14.568402,"marketCap":1911998142},{"date":"2025-02-07","current":15.738305,"twenty":4.275919,"median":9.466344,"eighty":14.652386,"marketCap":1964612662},{"date":"2025-02-14","current":15.435698,"twenty":4.275919,"median":9.483084,"eighty":14.687048,"marketCap":1926838135},{"date":"2025-02-21","current":16.178708,"twenty":4.275919,"median":9.514397,"eighty":14.715407,"marketCap":2019588089},{"date":"2025-02-28","current":15.284394,"twenty":4.275919,"median":9.568033,"eighty":14.816241,"marketCap":1907950871},{"date":"2025-03-07","current":19.286086,"twenty":4.270877,"median":9.582779,"eighty":14.884457,"marketCap":1781050742},{"date":"2025-03-14","current":19.942323,"twenty":4.270877,"median":9.582779,"eighty":14.985042,"marketCap":1841653603},{"date":"2025-03-21","current":19.862116,"twenty":4.270877,"median":9.595365,"eighty":15.085182,"marketCap":1834246586},{"date":"2025-03-28","current":19.719932,"twenty":4.270877,"median":9.649313,"eighty":15.125044,"marketCap":1821115967},{"date":"2025-04-04","current":20.186589,"twenty":4.270877,"median":9.689317,"eighty":15.233006,"marketCap":1864211334},{"date":"2025-04-11","current":16.708531,"twenty":4.275919,"median":9.707094,"eighty":15.273586,"marketCap":1543016172},{"date":"2025-04-17","current":18.524121,"twenty":4.275919,"median":9.710303,"eighty":15.333027,"marketCap":1710684087},{"date":"2025-04-25","current":19.18765,"twenty":4.270877,"median":9.726256,"eighty":15.373223,"marketCap":1771960313},{"date":"2025-04-29","current":18.932447,"twenty":4.270877,"median":9.726256,"eighty":15.400519,"marketCap":1748392534}],"updateTime":1746024418534}}}